Press Release
50 Years of Blood Pressure Monitor history
Press Release
50 Years of Blood Pressure Monitor history
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor history
The importance of home blood pressure monitoring
OMRON has always believed in the importance of home blood pressure monitoring, even when blood pressure readings could only be obtained at medical facilities. In 1991, the Company launched the world's first automated blood pressure monitor with IntelliSense¹ for greater accuracy and ease of use than manual monitors. In parallel with the advancement of blood pressure monitors, the Company worked continuously to improve and developed the pre-formed cuff that the user can wrap around their arm securely and easily, and further innovation led to the e-Fit Cuff, which was designed to reduce users’ discomfort during cuff inflation. Moreover, the Company has been focusing on enhancing usability and measurement accuracy by, expanding the range of support functions to ensure that the user maintains the correct measurement posture.
HEM-1, the first blood pressure monitor / HEM-706, the world's first fuzzy logic automatic blood pressure monitor
HEM-1, the first blood pressure monitor / HEM-706, the world's first fuzzy logic automatic blood pressure monitor
Raising awareness of the importance of home blood pressure monitoring
In addition, the company has worked to raise awareness of the importance of home blood pressure monitoring among medical professionals. The Company supported the Ohasama Study, which was started in 1986 in Ohasama, Iwate Prefecture, by providing around 300 units of OMRON blood pressure monitors for use in the research. Ohasama was notable for high and increasing incidence rates of cardiovascular diseases due to the area’s cold climate. To counter this problem, public health nurses worked to improve community’s health by having them measure their blood pressure at home and advising them based on their self-measured day-to-day blood pressure data. This study continued for more than 35 years and its findings, which confirmed the benefits of home blood pressure monitoring, have been incorporated into the hypertension management guidelines issued in various countries.
Digital technology, remote patient monitoring service
OMRON Healthcare has continued to pursue the challenge of adopting digital technology for blood pressure management. In 2010, the Company launched the health management service, WellnessLINK, on the Japanese market. The smartphone app for health management, OMRON connect, is now available in more than 110 countries. Moreover, in 2020, the Company launched a remote patient monitoring service in the U.S. This service enables users to share their blood pressure readings at home with physicians, promoting cardiovascular disease management before it worsens. OMRON has expanded its business scope by manufacturing and distributing a range of products and services that support hypertension treatments.
Pioneereing, innovative devices
OMRON Healthcare is also committed to developing innovative devices. These developments include the world’s first clinically accurate wearable blood pressure monitor, HeartGuide, and an upper-arm blood pressure monitors with built-in electrocardiogram (ECG) technology to facilitate the early detection of atrial fibrillation, a known risk factor for cardiogenic brain embolism.
HCR-6900T-M, Wearable blood pressure monitor / HCR-7800T, Upper-arm blood pressure monitor with ECG
HCR-6900T-M, Wearable blood pressure monitor / HCR-7800T, Upper-arm blood pressure monitor with ECG
Going for Zero
OMRON's Cardiovascular Business domain has set forth a vision of "Going for Zero" which aims to eliminate cerebrovascular and cardiovascular events. By developing devices and services and promoting home blood pressure monitoring and ECG recording, OMRON is dedicated to improving the quality of life for people worldwide, contributing to healthy and comfortable lives.
Message from Ayumu Okada
This year, we are celebrating the 50th anniversary of the launch of OMRON blood pressure monitors. On this happy occasion, I would like to express my heartfelt appreciation to all our valued customers for their continuing support of our blood pressure monitors. Cerebro-cardiovascular diseases are known to be the leading cause of death globally, and as populations in many countries continue to age, the number of patients suffering from these diseases is expected to increase even more. We remain committed to fulfilling the vision of “Going for ZERO” (achieving zero cerebro-cardiovascular events) that we have set for our Cardiovascular Business. Going forward, we will continue contributing to extending healthy life expectancy for people around the world by introducing devices and services tailored to solving health-related issues.
History of blood pressure monitor development
For the detailed information of the Company’s achievements and the future vision for realizing the vision of Zero cerebrovascular and cardiovascular events, please visit here:
